virogin.comVirogin Biotech
virogin.com Profile
virogin.com is a domain
that was created on 2015-05-17,making it 9 years ago.
It has several subdomains, such as ca.virogin.com , among others.
Description：Virogin Biotech Limited Leading oncolytic...
Discover virogin.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
virogin.com Information
| HomePage size: 53.76 KB |
| Page Load Time: 0.353234 Seconds |
| Website IP Address: 198.49.23.145 |
virogin.com Similar Website
| IO Biotech, Inc. - Invest in combination cancer therapy |
| American BioTech Supply – NSF/ANSI 456 Compliance |
| Biotech | Pall Corporation |
| BIOTECH |
| Biotech and Pharmaceutical Industry Resources |
| BioTECH @ Richmond Heights 9-12 | The Only Conservation Biology Public Magnet High School |
| Biotech & Pharma | Informa Connect |
| Biotech Colleges in Maharashtra | RGITBT | Bharati Vidyapeeth |
| Virogin Biotech |
| AC2 Bio-Link | Promoting Biotech Education in Texas and Kentucky |
| NCBiotech Company Directory | We make connections that create biotech jobs. |
| Science Careers Forum - Biotech, Pharmaceutical, Faculty, Postdoc jobs on Science Careers |
| Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace |
| GC biotech webshop – GC biotech – Translating Life Sciences Into |
virogin.com PopUrls
| Virogin Biotech https://virogin.com/ |
| About https://virogin.com/about/ |
| Pipeline https://virogin.com/pipeline/ |
| VG161 https://virogin.com/vg161/ |
| VG201 https://virogin.com/vg201/ |
| News https://virogin.com/news/ |
| Publications https://virogin.com/publications/ |
| saRNA - Virogin https://virogin.com/sarna/ |
| Contact https://virogin.com/contact/ |
| Virogin Announces its Publication of HPV mRNA cancer vaccine expressing ... https://virogin.com/virogin-announces-its-publication-of-hpv-mrna-cancer-vaccine-expressing-apc-targeting-antigen-in-immunology/ |
| VIROGIN Receives FDA Fast Track Designation for VG161, a Novel Therapy ... https://virogin.com/virogin-receives-fda-fast-track-designation-for-vg161-a-novel-therapy-candidate-for-the-treatment-of-advanced-hepatocellular-carci |
| Virogin Biotech Receives IND Approval from the U.S. FDA for VG201 https://virogin.com/virogin-biotech-receives-ind-approval-from-the-u-s-fda-for-vg201/ |
| Virogin Biotech Announces Dosing the First US Patient in a Phase 1 ... https://virogin.com/virogin-biotech-announces-dosing-the-first-us-patient-in-a-phase-1-study-of-vg201-for-patients-with-advanced-solid-tumors/ |
| VG161 granted for FDA Orphan Drug Designation - Virogin https://virogin.com/vg161-granted-for-fda-orphan-drug-designation/ |
| Virogin Biotech Receives IND Approvals from Chinese NMPA for VG201 and ... https://virogin.com/virogin-biotech-receives-ind-approvals-from-chinese-nmpa-for-vg201-and-vg161/ |
virogin.com DNS
| A virogin.com. 1799 IN A 23.185.0.3 |
| AAAA virogin.com. 1799 IN AAAA 2620:12a:8000::3 |
| MX virogin.com. 1799 IN MX 0 virogin-com.mail.protection.outlook.com. |
| NS virogin.com. 1800 IN NS dns1.registrar-servers.com. |
| TXT virogin.com. 1799 IN TXT sendinblue-code:f2d9c74d17a78d86d16e9d15cc48eab7 |
virogin.com Httpheader
| date: Fri, 28 Aug 2020 22:03:56 GMT |
| strict-transport-security: max-age=0 |
| expires: Thu, 01 Jan 1970 00:00:00 GMT |
| x-content-type-options: nosniff |
| content-type: text/html;charset=utf-8 |
| content-encoding: gzip |
| etag: W/"cc4b26e6e60e4e5b9735324e5d28c208" |
| content-length: 13315 |
| Vary: Accept-Encoding |
| Age: 511256 |
| Set-Cookie: crumb=BetfuRS598VGZDRjYzlhNzQzNTliOGNkMzI0OWVkMGEzZjA5N2Ew;Path=/ |
| Accept-Ranges: bytes |
| x-contextid: P8ptWd39/Aloce0ZG |
| server: Squarespace |
virogin.com Meta Info
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| charset="utf-8" |
| content="Virogin Biotech" property="og:site_name" |
| content="Virogin Biotech" property="og:title"/ |
| content="https://virogin.com" property="og:url"/ |
| content="website" property="og:type"/ |
| content="Virogin Biotech Limited Leading oncolytic virotherapy" property="og:description"/ |
| content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" property="og:image"/ |
| content="1250" property="og:image:width"/ |
| content="648" property="og:image:height"/ |
| content="Virogin Biotech" itemprop="name"/ |
| content="https://virogin.com" itemprop="url"/ |
| content="Virogin Biotech Limited Leading oncolytic virotherapy" itemprop="description"/ |
| content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" itemprop="thumbnailUrl"/ |
| content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" itemprop="image"/ |
| content="Virogin Biotech" name="twitter:title"/ |
| content="http://static1.squarespace.com/static/5b60c583a2772c966cdcc93c/t/5c9e97eb2cca3c0001a44e08/1553897452789/VB+new+logo.png?format=1500w" name="twitter:image"/ |
| content="https://virogin.com" name="twitter:url"/ |
| content="summary" name="twitter:card"/ |
| content="Virogin Biotech Limited Leading oncolytic virotherapy" name="twitter:description"/ |
| content="" name="description"/ |
virogin.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
virogin.com Html To Plain Text
Background Leadership Team Scientific Advisory Board Technology Challenges Facing Oncolytic Virotherapy Synerlytic™ Platform Pipeline Business Development Partnering Investors News Contact UsBackground Leadership Team Scientific Advisory Board Technology Challenges Facing Oncolytic Virotherapy Synerlytic™ Platform Pipeline Business Development Partnering Investors News Contact Us Virotherapy to Ignite Immunotherapy VIROGIN AIMS TO BE A GLOBAL, BEST-IN-CLASS ONCOLYTIC VIRUS COMPANY THAT CREATES IMPACTFUL DRUGS FOR PATIENTS OF THE HIGHEST MEDICAL NEED. OUR MISSION IS TO DEVELOP NEXT GENERATION ONCOLYTIC VIROTHERAPIES TO ENHANCE THE SYSTEMIC ANTITUMOR IMMUNITY. Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Learn About Our Technology Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market. Meet Our Leadership Team LATEST NEWS Featured Jan 22, 2020 Obtains Approval to Begin Phase I Clinical Trial in Australia Jan 22, 2020 Jan 22, 2020 Oct 23, 2019 Appoints New Advisors to Complement its Scientific Advisory Board Oct 23, 2019 Oct 23, 2019 May 8, 2019 to Form a Joint Venture with China’s Largest Pharmaceutical Company to Commercialize Oncolytic Virotherapies May 8, 2019 May 8, 2019 Read More3800 Wesbrook Mall, Vancouver, BC, V6S 2L9, Canada...
virogin.com Whois
Domain Name: VIROGIN.COM Registry Domain ID: 1929677149_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2024-04-18T09:39:35Z Creation Date: 2015-05-17T04:00:54Z Registry Expiry Date: 2025-05-17T04:00:54Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTRAR-SERVERS.COM Name Server: DNS2.REGISTRAR-SERVERS.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:30:02Z <<<